ReviewFrontiers in oncology2018
ALK Inhibitors in the Treatment of ALK Positive NSCLC.
Muhammad Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled itcites it
ReviewFrontiers in oncology2018
Muhammad Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.